Davoudabadi Sara, Goudarzi Hossein, Goudarzi Mehdi, Ardebili Abdollah, Faghihloo Ebrahim, Sharahi Javad Yasbolaghi, Hashemi Ali
1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2 Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Acta Microbiol Immunol Hung. 2021 Sep 20. doi: 10.1556/030.2021.01562.
In this study, we focused on the emergence of extensively drug-resistant (XDR), pandrug-resistant (PDR), and hypervirulent Klebsiella pneumoniae (hvKP) in Iran. During 2018 to 2020 a total of 52 K. pneumoniae isolates were collected from different clinical specimens. The hvKP isolates were identified by PCR amplification of virulence and capsular serotype-specific genes. Hypermucoviscous K. pneumoniae (hmKP) were identified by string test. Carbapenem-resistant hvKP (CR-hvKP), multidrug-resistant hvKP (MDR-hvKP), extensively drug-resistant hvKP (XDR-hvKP), and pandrug-resistant hvKP (PDR-hvKP) were determined by disc diffusion method, Carba-NP test and PCR method. XDR-hvKP isolates were typed by multilocus sequence typing (MLST). Among all K. pneumoniae isolates 14 (26.9%) were identified as hvKP and 78.6% (11/14) of them were hmKP however, none of the classic K. pneumoniae (cKP) isolates were hmKP. The predominant capsular serotype of hvKP was K2 (42.85%) followed by K1 (35.71%). The prevalence of MDR-hvKP, XDR-hvKP and PDR-hvKP isolates were 6 (42.9%), 5 (35.7%) and 1 (7.1%), respectively. ESBL production was found in 85.7% of hvKP isolates and most of them carried bla TEM gene (78.6%) and 6 isolates (42.9%) were CR-hvKP. Among hvKP isolates, 1 (7.1%), 2 (14.3%), 3 (21.4%), 8 (28.6%), and 11 (78.6%) carried bla NDM-6, bla OXA-48, bla CTX-M, bla SHV, and bla TEM genes, respectively. According to MLST analysis, 2, 1, 1, and 1 XDR-hvKP isolates belonged to ST15, ST377, ST442, and ST147, respectively. The occurrence of such isolates is deeply concerning due to the combination of hypervirulence and extensively drug-resistance or pandrug-resistance.
在本研究中,我们聚焦于伊朗广泛耐药(XDR)、泛耐药(PDR)以及高毒力肺炎克雷伯菌(hvKP)的出现情况。在2018年至2020年期间,共从不同临床标本中收集了52株肺炎克雷伯菌分离株。通过对毒力和荚膜血清型特异性基因进行PCR扩增来鉴定hvKP分离株。通过拉丝试验鉴定高黏液型肺炎克雷伯菌(hmKP)。采用纸片扩散法、Carba - NP试验和PCR方法来确定耐碳青霉烯类hvKP(CR - hvKP)、多重耐药hvKP(MDR - hvKP)、广泛耐药hvKP(XDR - hvKP)和泛耐药hvKP(PDR - hvKP)。通过多位点序列分型(MLST)对XDR - hvKP分离株进行分型。在所有肺炎克雷伯菌分离株中,14株(26.9%)被鉴定为hvKP,其中78.6%(11/14)为hmKP,然而,经典肺炎克雷伯菌(cKP)分离株中没有一株是hmKP。hvKP的主要荚膜血清型是K2(42.85%),其次是K1(35.71%)。MDR - hvKP、XDR - hvKP和PDR - hvKP分离株的患病率分别为6株(42.9%)、5株(35.7%)和1株(7.1%)。在85.7%的hvKP分离株中发现产超广谱β - 内酰胺酶(ESBL),其中大多数携带bla TEM基因(78.6%),6株(42.9%)为CR - hvKP。在hvKP分离株中,分别有1株(7.1%)、2株(14.3%)、3株(21.4%)、8株(28.6%)和11株(78.6%)携带bla NDM - 6、bla OXA - 48、bla CTX - M、bla SHV和bla TEM基因。根据MLST分析,2株、1株、1株和1株XDR - hvKP分离株分别属于ST15、ST377、ST442和ST147。由于高毒力与广泛耐药或泛耐药的结合,此类分离株的出现令人深感担忧。